MindBio.....It's Final but it's Not Finished.
Landmark Depression Trial Enrols Final Patient
Read issue →Mindbio Enrols 85th Patient into Phase 2B Microdosing Depression Trial
Landmark Depression Trial Approaches Completion.
Read issue →MindBio launches Booze AI to investors in Silicon Valley
app.booze-ai.com. The World's First Voice Activated & AI Powered Blood Alcohol Estimator on a Smartphone
Read issue →Mindbio Advances 80th Patient into Landmark Phase 2B Microdosing Depression Trial
Landmark Phase 2B Clinical Trial Approaches Completion.
Read issue →MindBio Advances two Phase 2B Microdosing trials, finalises acquisition of Life AI Corp
Multiple Phase 2B trials currently dosing and underway.
Read issue →MindBio Announces Major Diagnostic Speech Discovery & Acquisition of Life AI Corp
Major Speech Discovery Announced by MindBio. Acquires Life AI Corp
Read issue →MindBio Therapeutics (CNSX:MBIO). Reports Remarkable Sustained Antidepressant Response in Clinical Trials
72% Reduction in Severity of Depression Recorded.
Read issue →Microdosing Trials in Advanced Stage Cancer Patients Reaches Dosing Milestone
At-Home Dosing in 20th Participant Begins
Read issue →